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In Vitro Myelosuppressive Effects of the Parvovirus Minute Virus of Mice (MVMi) on Hematopoietic Stem and Committed Progenitor Cells
By Jose C. Segovia, Almudena Real, Juan A. Bueren, and Jose M. Almendral
The interaction of two strains of the parvovirus minute virus of mice (MVM) with the mouse hematopoietic system has been studied. The immunosuppressive strain MVMi, but not the prototype virus MVMp, inhibited hematopoiesis in vitro, as judged by colony-forming assays of the erythroid burstforming unit and granulocyte-monocyte colony-forming unit (CFU-GM) progenitors. Interestingly, primitive hematopoietic cells of the stem compartment (CFU-S,,), were equally susceptible to the MVMi cytotoxic infection, unravelling an unprecedented feature of virus-hematopoiesis interactions. The replication of both strains of MVM virus was evaluated in primary myeloid cells of long-term bone marrow cultures. A high viral DNA synthesis and maturation was observed in
MVMi-infected myeloid cells, but it was undetectable in
ARVOVIRUSES ARE small single-stranded DNA P viruses that depend for their replication on functions transiently expressed during the S phase of the cell cycle.' This dependence makes organs and tissues that are undergoing rapid proliferation especially susceptible to the parvovirus cytotoxic effects. One further requirement for parvovirus multiplication concerns the differentiation of the target cell, relying on interactions between viral determinants and differentially regulated cellular functions.2x3
The hematopoietic system offers a wide spectrum of dividing cells at different stages of differentiation and commitment, potentially susceptible to the parvovirus attack. In fact, although the pattern of diseases following parvovirus inoculation in experimental and domestic animals are fetal and neonatal death, congenital malformations, enteritis, hepatitis, myocarditis, cerebellar ataxia, and others: hematopoietic disorders are also frequently observed in the form of leukopenias and alterations in the bone marrow (BM).4-6 While all these evidences suggest that the hematopoietic progenitor compartment has been disturbed, the susceptibility of such cells to the direct cytopathic effect of the animal parvoviruses has only recently been reported for the feline parvovir~s.~ In humans, the interaction of parvoviruses with the hematopoietic system has been well documented in infections by the parvovirus B19. The virus is associated with a o 1991 by The American Society of Hematology.
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MVMp infections; moreover, the expression of the cytotoxic nonstructural NS-1 protein, a more reliable parameter of cell permissiveness to MVM infection, was only detected in MVMi-infected cells. Correspondingly, MVMi was propagated to high titers of infectious virus and it mediated an acute myelosuppression in these cultures. We conclude that MVMi has a wider tropism than was previously suspected and it is proposed that cytotoxic infection of hematopoietic stem cells, besides that of committed progenitors, may provide an additional basis to understand the pathogenesis of certain animal and human bone marrow failures of viral etiology.
o 1991 by The American Society of Hematology. diversity of diseases,' being the etiological agent of "erythema infectiosum" in children and causing several congenital abnormalities and hydrop fetalis. In adults, clinical symptoms are particularly severe in individuals with hemoglobinopathies that have an accelerated rate of erythropoiesis, which can lead to a syndrome termed transient aplastic crisis.' This virus inhibits the erythroid colonyforming unit (CFU-E) and erythroid burst-forming unit (BFU-E) progenitors,'o3'' but not other committed granulocyte-monocyte (CFU-GM) or pluripotent hematopoietic progenitors (CFU-Mix). B19 is propagated in human erythroid cultures derived from fetal liver or bone and the susceptibility of these cells to B19 increases with differentiation." Nevertheless, the infection of cells of the stem compartment by B19 virus has not been clearly worked out.
In the mouse, two independent strains of the parvovirus minute virus of mice (MVM) have been described. The prototype strain, MVMp, was originally isolated from a murine adenovirus stock and was shown to replicate efficiently in mouse fibroblasts.'6 The immunosuppressive strain, MVMi, was recovered from an EL-4 T-cell lymphoma culture17 and was shown to interfere with a number of T-cell functions in ~i t r o . '~~'~ MVMp and MVMi have been shown to interact productively or restrictively with cell lines in vitro" and their respective tropism were determined by the interaction of a region of the capsid protein^^'.'^ with intracellular factors.24 Intranasal inoculations in newborn mice showed that MVMp is not pathogenic. On the other hand, MVMi replicates in several organs and tissues, but has no demonstrable effects on T-cell functions in vivo.25 Despite these studies on infection of lymphoid cells by the MVMi parvovirus, the question of whether any of the MVM strains infects cells of the hematopoietic system remains unanswered.
We undertook the present study to investigate comparatively MVMp and MVMi interactions with the hematopoietic system and to understand the characteristics of this interaction. We have studied the proliferative integrity of hematopoietic progenitors and stem cells on MVM infection and the ability of the virus to accomplish its life cycle (DNA replication, proteins synthesis, and infectious virus 
MATERIALS AND METHODS
Cell lines and viruses. MVMi and the T-cell lymphoma line EL-4 used to grow it were kindly provided by B. Hirt (Swiss Inst for Exp Cancer Res, Epalinges, Switzerland). MVMp, the A9 cell line of mouse fibroblasts used to propagate and assay this strain, and the human SV40 transformed fibroblast cell line NB324K for plaque assay MVMi, were generously supplied by J. Rommelaere (Institut Pasteur, Lille, France). Cells were cultured in Dubecco's Modified Eagle Medium (DMEM; GIBCO Laboratories, Grand Island, NY) supplemented with 5% inactivated fetal bovine serum (FBS). Virus stocks were prepared by low-multiplicity infection (5 x plaque forming units [PFUJicell) of the corresponding cell line. In all the experiments performed in this work we have used purified viruses banded in density gradients as described below.
Mice. We used 12-to 14-week-old Fl(C57B1 X BALBlc) mice that were bred in our laboratory under standard conditions and maintained in a 7 AM to 7 PM light-dark cycle with food and water ad libitum. Mice were proved to be parvovirus-free by plaque assay in NB324K cells incubated with diluted mouse serum and also seronegative to MVM by the neutralization and immunoblot tests described below, as well as by immunofluorescence of MVMpinfected A9 cells.
Reference titers for MVMp and MVMi viruses were obtained by respective plaque assays on A9 and NB324K indicator cell lines as described.% To visualize the plaques, monolayers were fixed overnight with 10% formaldehyde and stained with 0.2% crystal violet. Virus titers were expressed as PFU per milliliter and the multiplicity of infection (MOI) as the number of PFU inoculated per cell. The plaque efficiency of the MVMp strain was between 10 to 20 times higher in NB324K than in A9 cell lines (not shown), in agreement with previously published data."
The virus purification method was based on published procedure~.*',~~ Briefly, cells were scraped off the plates directly into the medium, collected by low-speed centrifugation, and resuspended in 20 mmol/L Tris pH 8.5,l mmol/L EDTA (TE buffer). Intracellular virus was released by lysing cells with three freeze-thaw cycles, followed by centrifugation to remove debris. Extracellular virus was recovered from the medium by overnight precipitation with 3.4% PEG-6000, 0.5 m o m NaCl at 4"C, and centrifugation at 8,OOOg for 30 minutes at 4°C. The virus was resuspended in TE buffer and pooled with intracellular virus. Clumps were disaggregated by gentle sonication, the suspension was made 5 mmol/L in MgCl, and digested with 20 F.g/mL DNase1 and RNaseA for 30 minutes at 37°C. The virus suspension was then adjusted to 1% sodium dodecyl sulfate (SDS), 5 mmol/L NaCl and centrifuged 18 hours at 16 Krpm and 15°C in a Beckman SW40 rotor (Beckman Instruments, Inc, Fullerton, CA) through a 20% sucrose cushion in 50 mmom Tris pH 8.0, 0.1 mol/L NaCI, 1 mmol/L EDTA, and 0.2% SDS. The virus pellet was resuspended in TE buffer plus 0.2% Sarkosyl, adjusted to a density of 1.38 g/mL in CsCI, and centrifuged at equilibrium for 42 hours at 48 Krpm and 5°C in a Beckman Ty65 rotor (Beckman Instruments). Gradients were fractionated and the virus protein distribution was determined by hemagglutination. Leading fractions of infectious virus, free of
Virus titration andpurification.
defective particles were pooled, dialyzed against T E buffer, and stored at 4°C as reference stocks of MVMp and MVMi viruses.
BM cells were obtained by flushing Iscove's Modified Dulbecco's Medium (IMDM; GIBCO) through the shaft of the femora and tibiae of at least three mice. Cells were dispersed with a 16 x 5 mm needle and the number of nucleated cells was determined in a ZM Counter (Coulter Electronics, Luton, UK).
When hematopoietic cells, essentially free from MVMi-susceptible T cells and MVMp potentially susceptible fibroblastic stromal cells were needed, nonadherent cells were collected from longterm BM cultures (LTBMCs) established 3 weeks earlier in Fischer's medium plus 20% horse serum (HS), mol/L hydrocortisone, and antibiotics and fed on a weekly Before performing the infection of these nonadherent cells, they were further incubated for 24 hours in the presence of 10% WEHI-3b as a source of stimulating factors to facilitate the virus progression in the infected cells.
Infection of BM or stimulated nonadherent LTBMC cells with MVM was performed at a concentration of 1 to 2 X lo6 cells/mL in IMDM with 2% FCS for 1.5 hours at 37°C and constant shaking (similar results could be obtained in a 4°C infection, data not shown). Afterwards, cells were washed with IMDM plus 10% FCS to remove most unadsorbed virus and resuspended in IMDM to perform further clonal assays of the BM progenitors, or in medium supplemented with 10% FBS and 10% WEHI-3b to analyse the virus growth in the myeloid LTBMC cells.
Hematopoietic progenitor cells committed to the granulocytehonocyte (CFU-GM) or erythroid lineage (BFU-E) were assessed in semisolid cultures, essentially as described."." The culture media consisted of IMDM, 30% FBS, 1 % deionized bovine serum albumin (Fraction V, Sigma Chemical Co, St Louis, MO), 10% WEHI-3b Conditioned medium, 0.8% methylcellulose (Dow Chemical Co, Midland, MI), 2 UimL of erythropoietin (Terry Fox Laboratory, Vancouver, Canada), mol/L a-thioglycerol, 2 mmol/L L-glutamine and lo-' mol/L Na,SeO,. Nucleated cells (10s) in a final volume of 0.9 mL were dispensed in three wells of a multiwell culture dish (24-well Costar plates; Costar Corp, Cambridge, MA) and colonies were scored under an inverted microscope 7 days after incubation at 37°C in a 5% CO, humidified atmosphere.
For the determination of hematopoietic precursors of the stem compartment, exogenous spleen colony-forming unit (CFU-S) assays" were performed, under conditions allowing the expression of primitive CFU-S." Recipient mice were total-body irradiated with 10.5 Gy in fractions of 5.0 Gy and 5.5 Gy spaced 4 hours apart, with a Philips MG323 X-ray equipment (Philips GmbH, Hamburg, Germany) at 300 kV, 12.8 mA (HVL3.2 mmCu) delivering a dose rate of 1.05 Gy/min. This irradiation regimen totally ablated the endogenous CFU-S that originates colonies on day 12 and allowed the survival of about 90% recipient mice. An appropriate number of BM cells to obtain about 10 colonies per spleen was injected into the recipients through the lateral tail vein. At day 12 after transplantation, mice were killed, their spleens excised, fixed in Telly's solution, and the number of colonies representing the CFU-S,,, counted under a dissecting microscope.
The spleenseeding efficiency (f) of the spleen colony forming cells (CFC-S) from normal and MVMi-infected BM, was measured by the retransplantation technique? modified as described." Cells, 4 x lo4, from mock-infected BM or 1.6 x los BM cells infected with MVMi at MOI 1 PFUkell, were injected into each recipient for the CFU-S,,, assay (10 recipients per group). Two parallel groups of five primary recipient mice were injected with 100 times more cells use only.
For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From (4 X 106 uninfected, 1.6 X lo7 MVMi-infected cells), killed 24 hours later, and spleen cell suspensions made in Hanks' solution. Fractions of one fifth and one twentieth of each spleen were injected into groups of 10 secondary recipients for further CFU-S,,, assay. The spleen-seeding efficiency was calculated from the ratio of secondary colonies obtained to primary CFU-S,, injected.
Nonadherent myeloid cells from LTBMCs, A9, or EL-4 cells were infected at MOI 4 PFU/cell with MVMp or MVMi. At the indicated hours postinfection (hpi) cells were pelleted, total protein extracts were prepared, and MVM replicative intermediates were purified by a modified Hirt pr~cedure,'~ with carrier tRNA to ensure quantitative yields. DNA was fractionated by agarose gel electrophoresis, blotted to nylon membranes (Genescreen-plus; Dupont, New England Nuclear, Boston, MA), and hybridized with MVMp DNA (very similar in sequence to MVMi38,39) gel-purified from a recombinant clone containing the entire virus genome (J.C. Ramirez and J.M. Almendral, unpublished results). The probe was labeled by randomprimingq to a specific activity of 1 to 2 x lo9 cpm/pg and hybridized overnight at 42°C in 50% formamide, 5X SSC (1X SSC is 0.15 mol/L NaCl plus 0.015 moVL sodium citrate), 5 x Denhardt solution, 10% dextran sulphate (Pharmacia Fine Chemicals, Uppsala, Sweden), 1% SDS, and 200 p, g of denatured salmon sperm DNNmL. Final washing of filters was at 56°C in 0.1X SSC, 0.5% SDS. Kodak X-Omat films (Eastman Kodak, Rochester, NY) were exposed to the filters with an intensifying screen at -70°C. Proteins were polyacrylamide gel electrophoresis (PAGE) fractionated, electroblotted to nitrocellulose filters:' and detected with antibodies and a color reaction with peroxidase following conventional procedures!' Antiserum again& purified MVMp capsid proteins (serologically undistinguishable from MVMi)24 was raised in rabbit and NS-1-specific antiserum was obtained by immunizing mice with a purified NS-l/pgal fusion protein (to be described elsewhere).
Viral DNA and protein analyses.
RESULTS

Susceptibility of murine committed myeloid progenitors to M 4 4 p and MI/1Mi infection. To assess the effects of MVM
infection on the proliferation and differentiation capacity of hematopoietic progenitors, BM cells were infected with purified MVMi or MVMp viruses and thereafter cultured in vitro to allow the expression of the CFU-GM and BFU-E progenitors. Because the susceptibility of cell lines to parvovirus infection is defined in terms of cell viability in relation to input virus, the infection was performed at different MOI and the percentage of these progenitors with proliferative integrity was estimated according to the number of viable colonies originated at each MOI. As seen in Fig 1, the viability of both CFU-GM and BFU-E decayed in proportion to the input of infectious MVMi. In contrast, the prototype MVMp only showed a slight effect on the viability of these cells (between 60% to 80% survival) at the higher MOIs.
To further support that this inhibition of in vitro hematopoiesis is a direct consequence of the MVMi infection of the progenitors, the viability of these cells was assessed after neutralizing the virus infectivity with antiserum raised against purified MVM capsids. infectivity is responsible for the inhibition of the colony formation ability of the CFU-GM and BFU-E progenitors.
Susceptibility of mouse hematopoietic stem cells to M44 infection. Because parvovirus multiplication relys on cellular functions expressed at appropriate differentiation states, other hematopoietic progenitors like those of the stem cell compartment might be potential target cells for MVMi or MVMp infections. Therefore, we have analyzed the effect of MVMi or MVMp infection at different MOI on the proliferative capacity of the multipotential spleen colony forming cell CFU-SI, that represents one of the earliest progenitors of the stem compartment for which a clonal assay is available. Figure 3 shows that the number of CFU-S,, decreased in a dose-related manner to the infectious MVMi input and with similar kinetics to that found in the committed progenitor assays, which suggests a similar susceptibility of the CFU-SI,,, CFU-GM, and BFU-E to the MVMi infection. Here again, a slight reduction in the CFU-S numbers (up to 80% survival) were obtained at the higher MOIs of MVMp.
To confirm that the susceptibility curve of the CFU-SI,, to the MVMi infection is not being influenced by a decrease in the spleen-seeding efficiency of the CFC-S, we have analysed in a single experiment the fraction of CFC-S use only. producing splenic colonies, either in mock-infected and in MVMi-infected (1 PFU/cell) BM. As shown in Table 1 , the seeding efficiency of surviving MVMi-infected CFC-S was similar to that obtained for uninfected BM, what conduces to a CFC-S survival fraction analogous to that observed for CFU-S (Fig 3 ) .
Macromolecularparameters of MI/1Mi and MI/1Mp growth in myeloid cells of mice. As the susceptibility of hematopoietic progenitors and stem cells to MVMi correlated with the input of infectious virus, one would expect this inhibition of proliferation to be a consequence of cytotoxic mechanisms underlying MVMi replication and not operating in MVMpinfected cells. To test this hypothesis and to determine the myeloid cells permissiveness to the replication of both MVM strains, we monitored the extension of two macromolecular parameters of virus growth in infected nonadherent cells from LTBMCs.
Myeloid cultures were infected at MOI 4 PFU/cell with MVMi or MVMp to ensure the infection of most cells and viral DNA replication and the synthesis of the nonstructural protein NS-1 were studied at early and late times of the viral cycle (5 and 17 hpi, respectively). In parallel, reference infections of the respective MVMi and MVMp permissive and restrictive cell lines were performed. Southern blots of Hirt supernatants of infected cultures showed (Fig 4A) The expression of the nonstructural NS-1 protein was chosen as a second and main parameter of MVM multiplication in myeloid cells, given that NS-1 is a multifunctional nuclear phosphoprotein involved in several critical steps of virus cycle. Immunoblots developed with specific NS-1 antiserum showed (Fig 4B) (Fig SA) that was not manifested in uninfected or MVMp-infected cultures. Earlier and more pronounced responses were observed at the progenitors level; the number of CFU-GM (Fig 5B) and BFU-E (Fig 5C) cells decreased sharply beyond 24 hours post-MVMi infection, but again no effect was observed in MVMp-infected cultures. Finally, MVMi titer increased up to 100-fold in the culture, with a production rate concomitant to the progressive progenitors depletion (Fig 5D) . These results demonstrate that MVMi is highly propagated in myeloid cells in culture. On the contrary and in agreement with the lack of cytotoxic infection in BM progenitors and NS-1 expression in myeloid cells, only a slow increase in MVMp titer was observed that did not correspond to the myeloid cells' depletion.
DISCUSSION
The experiments presented in this report were conducted to investigate the characteristics of the interaction between murine hematopoietic progenitors and two strains of the parvovirus MVM in terms of cell susceptibility and virus gene expression and multiplication.
Our results demonstrate that, under the assayed conditions of infection, the proliferative capacity of committed progenitors (BFU-E and CFU-GM) and pluripotent stem cells (CFU-S,,) is susceptible to MVMi virus. This effect of MVMi is inherent to virus infectivity as was mediated by purified virus, was reversible with neutralizing MVM antiserum, and correlated with the input of infectious virus. The proliferative inactivation kinetics of these precursors were in fair accord with statistical predictions of the Poisson distribution for cell-virus interactions, suggesting a direct cytotoxic infection of these precursors and that the MVMiinfective unit be the same for BFU-E, CFU-GM, and CFU-S as well as for NB324K cells, currently the most susceptible cell line used to titrate the MVMi. Although other mechanisms like the reinfection of developing colonies in the CFU-S assays could mediate and modulate in part the observed effects, the in vitro incubation of BM cells 4 hours postinfection with mouse-neutralizing MVM antiserum, or the periodical injection of this antiserum into recipients of the CFU-S assay, did not vary the number of spleen colonies (not shown). Other possible misleading effects on the CFU-S susceptibility curve, like a selective decrease in the seeding efficiency of infected CFC-S, was also ruled out by the finding of a seeding efficiency (Table  1) close to reported values43 that implies a CFC-S survival analogous to that obtained for CFU-S at the same MOI (Fig 3) .
In marked contrast to the MVMi effect, hematopoietic progenitors and stem cells were not susceptible to MVMp. The slight reduction in viability observed at high MOI of MVMp virus is analogous to that found in infected resistant cells that do not support the replication of parvovirus," and The MVMi infection of myeloid cells from LTBMCs shown in Fig 5 demonstrates a progressive decrease in the proliferative capacity of progenitor cells concomitant with infectious virus production in the cultures; meanwhile the total cell number is only brought down some days later. As expected by the above experiments, none of these effects were observed in MVMp infection and the virus was not appreciably propagated in this system. The ninefold increase of MVMp titer may rather be a consequence of a low virus replication in some residual stromal fibroblastic cells that were progressively apparent in these cultures.
Taken together, these experiments demonstrate that the strain MVMi, previously described as immunosuppressive, is highly cytotoxic to the myeloid system. So, in addition to its ability to inhibit various functions of T cells in vitro,'* the myelotropism should be considered now a relevant property of MVMi biology, characterized by a wide myelosuppressive potential within the hematopoietic system that includes erythroid and granulomacrophage progenitors as well as cells of the stem compartment. Thus, the term MVMim could be a more accurate designation for this strain.
Many viruses infecting hematopoietic cells of animals and humans and causing BM failure by diverse mechanisms have been described. Flavivirus, like dengue virus, propagates in human BM cells. Although not cytopathic, this virus alters the morphology of the colony and slows cell proliferation.6z Hematopoietic precursors were shown to be decreased in humans and simians infected with immunodeficiency retrovir~s>~-~' and indirect manifestations of no cytopathic macrophage infection or immune-mediated suppression, were proposed. Other retrovirus, the feline leukemia virus, in addition to immunodeficiency and proliferative diseases, causes rapid depletion of early erythroid precursors when injected into cats.66 Viruses with liver tropism, like the mouse hepatitis virus (MHV-3)h7 or hepadna viruses, are associated with suppression of hematopoiesis and the hepatitis B virus inhibits colony formation of human hematopoietic progenitor cells.68 Myelosuppression mediated by cytomegalovirus implies the perturbation of stromal cells functions that support hematopoiesis, as well as a direct effect on myeloid cell^.^^.^'
Other herpes viruses may incite a host cytotoxic immune response against hematopoietic cells.72 Panleukopenia and erythropenia leading to eventual aplastic crises have been described in human and animals as a direct consequence of parvovirus cytotoxic infe~tion,~.' but to our knowledge this report on MVMi infection is the first evidence of a cytotoxic interaction of a virus with a hematopoietic pluripotent progenitor with self-renewing capacity. Our data provide new insights to explain BM failures in animals and humans infected by parvoviruses. Effects on the stem cell compartment may unleash pathologic manifestations and clinical symptoms that are the consequences of impaired myelopoiesis and lymphopoiesis or BM aplasia in immunocompromised hosts.
The susceptibility to MVMi infection by the CFU-S stem cell may be regarded as an unexpected result because these cells have a proliferative rate that is characteristically low in normal healthy mice,73 and cell proliferation is essential both for parvovirus DNA replication and for the expression of cytotoxic proteins in the infected cells. In our experiments, although hematopoietic stem cells should be quiescent when exposed to MVMi, they were further stimulated to proliferate when transplanted into lethally irradiated mice to assess the CFU-S precursor. This conditional susceptibility of these cells opens the possibility that the stem compartment may be a reservoir of parvovirus under normal conditions that would be manifested when such cells were triggered into cycle in response to hematologic damage or physiologic requirements. Latent or persistent infections would have epidemiologic relevance as a mechanism of parvovirus permanence in nature, as well as in pathologic processes like chronic BM failures of inapparently infected immunodepressed patients. Experiments are currently in progress to evaluate these hypotheses in vivo in the MVMi-mouse model. 
